These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 3237275

  • 21. Changes in the molecular sieve of glomerular basement membrane in rats with aminonucleoside nephrosis.
    Takaya Y, Ota Z, Makino H, Kida K, Miyoshi A, Hiramatsu M, Takahashi K, Ofuji T.
    Acta Med Okayama; 1980 Feb; 34(1):67-70. PubMed ID: 6446842
    [Abstract] [Full Text] [Related]

  • 22. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ.
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [Abstract] [Full Text] [Related]

  • 23. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY.
    Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817
    [Abstract] [Full Text] [Related]

  • 24. Glomerular epithelial abnormalities associated with the onset of proteinuria in aminonucleoside nephrosis.
    Messina A, Davies DJ, Dillane PC, Ryan GB.
    Am J Pathol; 1987 Feb 28; 126(2):220-9. PubMed ID: 3826295
    [Abstract] [Full Text] [Related]

  • 25. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
    Nakamura T, Kimura K, Ebihara I, Takahashi T, Tomino Y, Aikawa M, Yazaki Y, Nagai R, Koide H.
    Clin Sci (Lond); 1995 Jul 28; 89(1):45-52. PubMed ID: 7671567
    [Abstract] [Full Text] [Related]

  • 26. An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis.
    Ryan GB, Karnovsky MJ.
    Kidney Int; 1975 Oct 28; 8(4):219-32. PubMed ID: 1104966
    [Abstract] [Full Text] [Related]

  • 27. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
    Kaplan BS, Renaud L, Drummond KN.
    Lab Invest; 1976 Feb 28; 34(2):174-8. PubMed ID: 1249918
    [Abstract] [Full Text] [Related]

  • 28. The relationship between glomerular function and podocyte structure of pre-proteinuria and acute nephrosis in puromycin aminonucleoside-induced rat models: a comparative electron microscopic study.
    Seçkin İ, Uzunalan M, Pekpak M, Köktürk S, Sönmez HA, Güngör ZB, Demirkiran ÖD, Saygi Hİ, Yaprak Saraç E.
    Rom J Morphol Embryol; 2017 Feb 28; 58(3):823-830. PubMed ID: 29250660
    [Abstract] [Full Text] [Related]

  • 29. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.
    Muroya Y, Ito O.
    Clin Exp Nephrol; 2016 Dec 28; 20(6):862-870. PubMed ID: 26949064
    [Abstract] [Full Text] [Related]

  • 30. Glomerular podocyte cell junctions in nephrotic syndrome. I. Freeze-fracture studies in rat aminonucleoside nephrosis.
    Kühn K, Sterzel RB, Reale E.
    J Submicrosc Cytol; 1981 Jul 28; 13(3):407-12. PubMed ID: 7334544
    [Abstract] [Full Text] [Related]

  • 31. Ultrastructural changes in glomerular epithelial cells in acute puromycin aminonucleoside nephrosis: a study by high-resolution scanning electron microscopy.
    Inokuchi S, Sakai T, Shirato I, Tomino Y, Koide H.
    Virchows Arch A Pathol Anat Histopathol; 1993 Jul 28; 423(2):111-9. PubMed ID: 8212539
    [Abstract] [Full Text] [Related]

  • 32. Demonstration of percellular channels in glamerular podocytes in aminonucleoside nephosis.
    Langer KH, Paul N, Thoenes W.
    Virchows Arch B Cell Pathol; 1974 Jul 28; 17(1):91-6. PubMed ID: 4217040
    [No Abstract] [Full Text] [Related]

  • 33. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM, Sharon Z, Pauli BU, Lewis EJ.
    Lab Invest; 1984 Dec 28; 51(6):690-6. PubMed ID: 6389977
    [Abstract] [Full Text] [Related]

  • 34. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
    Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T.
    Clin Exp Nephrol; 2009 Oct 28; 13(5):438-446. PubMed ID: 19452240
    [Abstract] [Full Text] [Related]

  • 35. Suppression of proteinuria by dipyridamole in rats with aminonucleoside nephropathy.
    Nagase M, Kumagai H, Honda N.
    Ren Physiol; 1984 Oct 28; 7(4):218-26. PubMed ID: 6473895
    [Abstract] [Full Text] [Related]

  • 36. Aminonucleoside nephrosis. I. Electron microscopic study of the renal lesion in rats.
    VERNIER RL, PAPERMASTER BW, GOOD RA.
    J Exp Med; 1959 Jan 01; 109(1):115-26. PubMed ID: 13611168
    [Abstract] [Full Text] [Related]

  • 37. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G, Imberti L, Rossini M, Morelli C, Carminati C, Cattaneo GM, Bertani T.
    J Clin Invest; 1985 Jan 01; 75(1):94-101. PubMed ID: 4038407
    [Abstract] [Full Text] [Related]

  • 38. Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury.
    Diamond JR, Pesek I, Ruggieri S, Karnovsky MJ.
    Am J Physiol; 1989 Nov 01; 257(5 Pt 2):F798-807. PubMed ID: 2589483
    [Abstract] [Full Text] [Related]

  • 39. Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
    Inokuchi S, Shirato I, Kobayashi N, Koide H, Tomino Y, Sakai T.
    Kidney Int; 1996 Oct 01; 50(4):1278-87. PubMed ID: 8887289
    [Abstract] [Full Text] [Related]

  • 40. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
    Higuchi A.
    Nihon Jinzo Gakkai Shi; 1990 Jul 01; 32(7):767-75. PubMed ID: 2273594
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.